Mapping "missing" conformations of ATP-gated P2X receptor ion channels

绘制 ATP 门控 P2X 受体离子通道“缺失”构象图

• 批准号: BB/P001076/1
• 负责人: Richard Evans
• 金额: $ 53.96万
• 依托单位: University of Leicester
• 依托单位国家: 英国
• 项目类别: Research Grant
• 财政年份: 2016
• 资助国家: 英国
• 起止时间: 2016 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=BB%2FP001076%2F1
• 关键词: Mapping; missing; conformations; ATP; gated

Cells within the body communicate with one-another through the release of chemicals recognised by specific cell surface receptors. One example of such a chemical is ATP that binds to P2X receptors (P2XRs) and activates them. In humans there are at least 13 different types of P2XR (e.g P2X1R and P2X7R) that vary in their properties, for example how long they are able to be "turned-on/activated". P2XRs play an important role in a range of normal bodily functions e.g. in control of blood clotting and taste sensation, as well being drug targets for the treatment of pain and neurodegenerative diseases e.g. Alzheimer's disease. P2XRs are membrane proteins with parts on the outside of the cell (extracellular) that recognize the ATP molecule, a channel region that passes through the cell wall (a valve/tap that regulates the movement of positively charged ions) and a region inside the cell (intracellular) that regulates how long the receptor is "ON" for (dependent on the receptor type). In the absence of ATP the P2XR channel is closed and "OFF". ATP binding to the extracellular region leads to a change in the shape of the receptor; an "ON" signal opening the channel (movement of positive ions through it excites the cell). Recent studies have shown the 3D structure of a P2XR in the "OFF" and "ATP-ON" states and this has provided a major advance in our understanding of how this novel family of receptors works. However, these are only two snapshots of the receptor, and it is clear that additional movements in the 3D shape are important that result in distinct forms of the receptor with special properties. This proposal aims to gain 3D structural information on three distinct "missing" conformations/states of the receptor. (i) A "relaxed-OFF" form of the receptor in the absence of ATP that may be important for understanding of how drugs work to block/stop the receptor being turned on. (ii) An "ATP-CLOSED" desensitized receptor, where after opening following ATP binding the channel closes (i.e. turns off); a feature of the P2X1R involved in blood clotting. (iii) An "ATP-EXTRA-ON" state where the channel region gets larger and allows large molecules to enter the cell; this is particularly associated with the P2X7R and its role in inflammation and cell death. Information on these additional "missing" structures is essential to understand the fundamental mechanisms associated with the activity of this distinct family of receptors. P2XRs are made up of different amino acid "building blocks" and these can be individually changed. Of particular use for this is mutating an amino acid to cysteine; this is a chemically unique amino acid that can be targeted with a wide range of cysteine-specific compounds. These bind to the cysteine residue and change the chemical properties/size. In normal P2XRs there are no cysteine residues available for modification and cysteine-specific compounds have no effect. Therefore we can introduce cysteine mutations at defined parts of the receptor and determine the effects of cysteine reactive compounds to investigate the structure. This will be carried out in the absence of ATP (relaxed-OFF), and in the presence of ATP at desensitizing P2XRs (ATP-CLOSED) and at the ATP-EXTRA-ON P2X7R. We will test whether an introduced residue is accessible (on the receptor surface or in the channel), and by varying the size of the cysteine reactive compound measure the dimensions around that residue as well as test the effects of the modification on ATP evoked responses. These results will give molecular dimensions that will then be used in computer based studies to map the molecular changes in the receptor and provide validated 3D models of the missing receptor structures. This will provide a fundamental insight into how P2XRs work at the molecular level, understanding variations between receptors, and why genetic mutations affect receptor properties that can lead to imbalances in signalling and disease.

体内的细胞通过释放特定细胞表面受体识别的化学物质相互交流。这种化学物质的一个例子是ATP，它与P2 X受体（P2 XR）结合并激活它们。在人类中，至少有13种不同类型的P2 XR（例如P2 X1 R和P2 X7 R），它们的特性各不相同，例如它们能够“打开/激活”多长时间。P2 XR在一系列正常身体功能中发挥重要作用，例如控制血液凝固和味觉，以及作为治疗疼痛和神经退行性疾病（例如阿尔茨海默病）的药物靶标。P2 XR是一种膜蛋白，其部分位于细胞外（细胞外），识别ATP分子，通道区域穿过细胞壁（调节带正电荷离子运动的阀门/龙头），细胞内（细胞内）区域调节受体“开启”多长时间（取决于受体类型）。在缺乏ATP的情况下，P2 XR通道关闭并“关闭”。ATP与细胞外区域的结合导致受体形状的变化;“ON”信号打开通道（正离子通过它的运动激发细胞）。最近的研究显示了P2 XR在“OFF”和“ATP-ON”状态下的3D结构，这为我们理解这种新型受体家族如何工作提供了重大进展。然而，这些只是受体的两个快照，很明显，3D形状中的额外运动是重要的，这导致了具有特殊性质的受体的不同形式。该提议旨在获得关于受体的三种不同“缺失”构象/状态的3D结构信息。(i)在缺乏ATP的情况下，受体的“松弛关闭”形式，这对于理解药物如何阻断/停止受体的开启可能是重要的。（ii）“ATP关闭”脱敏受体，其中在ATP结合后打开通道后关闭（即关闭）;参与血液凝固的P2 X1 R的特征。(iii)一种“ATP-EXTRA-ON”状态，其中通道区域变大并允许大分子进入细胞;这与P2 X7 R及其在炎症和细胞死亡中的作用特别相关。关于这些额外的“缺失”结构的信息对于理解与这种独特的受体家族的活性相关的基本机制是必不可少的。P2 XR由不同的氨基酸“构建块”组成，并且这些可以单独改变。对此特别有用的是将氨基酸突变为半胱氨酸;这是一种化学上独特的氨基酸，可以用广泛的半胱氨酸特异性化合物靶向。它们与半胱氨酸残基结合并改变化学性质/大小。在正常的P2 XR中，没有半胱氨酸残基可用于修饰，半胱氨酸特异性化合物没有作用。因此，我们可以在受体的限定部分引入半胱氨酸突变，并确定半胱氨酸反应性化合物的作用以研究结构。这将在不存在ATP（松弛-关闭）的情况下，以及在存在ATP的情况下，在脱敏P2 XR（ATP-关闭）和ATP-额外-ON P2 X7 R下进行。我们将测试引入的残基是否可接近（在受体表面或通道中），并通过改变半胱氨酸反应性化合物的大小来测量该残基周围的尺寸，以及测试修饰对ATP诱发反应的影响。这些结果将给出分子尺寸，然后将其用于基于计算机的研究中，以绘制受体中的分子变化，并提供缺失受体结构的经验证的3D模型。这将为P2 XR在分子水平上如何工作提供基本的见解，了解受体之间的差异，以及为什么基因突变会影响受体特性，从而导致信号传导和疾病的不平衡。

项目成果

Identification of a distinct desensitisation gate in the ATP-gated P2X2 receptor

• DOI: 10.1016/j.bbrc.2019.12.028
• 发表时间: 2020-02-26
• 期刊: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
• 影响因子: 3.1
• 作者: Stavrou，Anastasios;Evans，Richard J.;Schmid，Ralf
• 通讯作者: Schmid，Ralf